Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines
Sinthujan Jegaskanda, Sarah F. Andrews, Adam K. Wheatley, Jonathan W. Yewdell, Adrian B. McDermott, Kanta Subbarao
Sinthujan Jegaskanda, Sarah F. Andrews, Adam K. Wheatley, Jonathan W. Yewdell, Adrian B. McDermott, Kanta Subbarao
View: Text | PDF
Research Article Infectious disease Vaccines

Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines

  • Text
  • PDF
Abstract

Broadly neutralizing Abs targeting the HA stem can provide broad protection against different influenza subtypes, raising the question of how best to elicit such Abs. We have previously demonstrated that vaccination with pandemic live-attenuated influenza vaccine (pLAIV) establishes immune memory for HA head-specific Abs. Here, we determine the extent to which matched versus mismatched LAIV-inactivated subunit vaccine (IIV) prime-boost vaccination elicits stem-specific memory B cells and Abs. We vaccinated African green monkeys with H5N1 pLAIV-pIIV or H5N1 pLAIV followed by seasonal IIV (sIIV) or with H5N1 pLAIV alone and measured Abs and HA-specific B cell responses. While we observed an increase in stem-specific memory B cells, head-specific memory B cell responses were substantially higher than stem-specific responses and were dominant even following boost with mismatched IIV. Neutralizing Abs against heterologous influenza viruses were undetectable. Head-specific B cells from draining lymph nodes exhibited germinal center markers, while stem-specific B cells found in the spleen and peripheral blood did not. Thus, although mismatched prime-boost generated a pool of stem-specific memory B cells, head-specific B cells and serum Abs substantially dominated the immune response. These findings have implications for including full-length native HA in prime-boost strategies intended to induce stem-specific Abs for universal influenza vaccination.

Authors

Sinthujan Jegaskanda, Sarah F. Andrews, Adam K. Wheatley, Jonathan W. Yewdell, Adrian B. McDermott, Kanta Subbarao

×

Figure 4

HA-specific memory B cells following mismatched prime-boost vaccination in lymphoid tissues.

Options: View larger image (or click on image) Download as PowerPoint
HA-specific memory B cells following mismatched prime-boost vaccination ...
(A) Representative plots of H5-specific IgG+ memory B cells (CD19+CD20+CD27+IgG+) from mediastinal, ipsilateral axillary, contralateral axillary lymph nodes (LN) and spleen at day 56 after pLAIV, which is day 28 after sIIV boost vaccination. (B) Frequency of H5+, H5+H1+, or H1+ memory B cells in submandibular, cervical, mediastinal, ipsilateral and contralateral axillary lymph nodes and spleen. (C) Representative plot of Ki67 and Bcl-6 expression of CD19+CD20+ B cells from mediastinal or ipsilateral axillary lymph nodes that are H5+, H5+H1+, or H1+ probe positive at day 56 after pLAIV (or day 28 after sIIV boost). (D) Analysis of Ki67 and Bcl-6 expression on H5+, H5+H1+, or H1+ probe–positive B cells in submandibular, cervical, mediastinal, ipsilateral and contralateral axillary lymph nodes and spleen at day 56 after pLAIV (or day 28 after sIIV boost) in 4 separate animals.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts